{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:41:20Z","timestamp":1788777680195,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,4]]},"DOI":"10.7759\/cureus.25656","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T14:39:46Z","timestamp":1654353586000},"source":"Crossref","is-referenced-by-count":2,"title":["Pregabalin Toxicity-Induced Posterior Reversible Encephalopathy Syndrome"],"prefix":"10.7759","author":[{"given":"Feng","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purushothaman","family":"Muthukanagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and misuse of pregabalin and gabapentin: a systematic review update","volume":"81","author":"Evoy KE","year":"2021","unstructured":"Evoy KE, Sadrameli S, Contreras J, Covvey JR, Peckham AM, Morrison MD. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2021, 81:125-56. 10.1007\/s40265-020-01432-7","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy KE","year":"2017","unstructured":"Evoy KE, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs. 2017, 77:403-26. 10.1007\/s40265-017-0700-x","journal-title":"Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird CR","year":"2014","unstructured":"Baird CR, Fox P, Colvin LA. Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers. Eur Addict Res. 2014, 20:115-8. 10.1159\/000355268","journal-title":"Eur Addict Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey J","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et al.. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996, 334:494-500. 10.1056\/NEJM199602223340803","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-4088-7.00109-7","article-title":"Posterior reversible encephalopathy syndrome","volume":"121","author":"Lamy C","year":"2014","unstructured":"Lamy C, Oppenheim C, Mas JL. Posterior reversible encephalopathy syndrome. Handb Clin Neurol. 2014, 121:1687-701. 10.1016\/B978-0-7020-4088-7.00109-7","journal-title":"Handb Clin Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features","volume":"29","author":"Bartynski WS","year":"2008","unstructured":"Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008, 29:1036-42. 10.3174\/ajnr.A0928","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.07.018","article-title":"Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics","volume":"404","author":"Tetsuka S","year":"2019","unstructured":"Tetsuka S, Ogawa T. Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics. J Neurol Sci. 2019, 404:72-9. 10.1016\/j.jns.2019.07.018","journal-title":"J Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski WS","year":"2008","unstructured":"Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008, 29:1043-9. 10.3174\/ajnr.A0929","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.46","article-title":"Clinical spectrum of reversible posterior leukoencephalopathy syndrome","volume":"65","author":"Lee VH","year":"2008","unstructured":"Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008, 65:205-10. 10.1001\/archneurol.2007.46","journal-title":"Arch Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0303-6","article-title":"Abuse potential of pregabalin: a systematic review","volume":"30","author":"Schjerning O","year":"2016","unstructured":"Schjerning O, Rosenzweig M, Potteg\u00e5rd A, Damkier P, Nielsen J. Abuse potential of pregabalin: a systematic review. CNS Drugs. 2016, 30:9-25. 10.1007\/s40263-015-0303-6","journal-title":"CNS Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14348","article-title":"Pregabalin poisoning and rising recreational use: a retrospective observational series","volume":"86","author":"Isoardi KZ","year":"2020","unstructured":"Isoardi KZ, Polkinghorne G, Harris K, Isbister GK. Pregabalin poisoning and rising recreational use: a retrospective observational series. Br J Clin Pharmacol. 2020, 86:2435-40. 10.1111\/bcp.14348","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000245","article-title":"Pregabalin toxicity manifesting as reversible encephalopathy with continuous triphasic waves in electroencephalogram","volume":"40","author":"Parekh M","year":"2017","unstructured":"Parekh M, Dash GK, Ahamed I. Pregabalin toxicity manifesting as reversible encephalopathy with continuous triphasic waves in electroencephalogram. Clin Neuropharmacol. 2017, 40:226-8. 10.1097\/WNF.0000000000000245","journal-title":"Clin Neuropharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.08.002","article-title":"Pregabalin intoxication-induced encephalopathy with triphasic waves","volume":"25","author":"Lee S","year":"2012","unstructured":"Lee S. Pregabalin intoxication-induced encephalopathy with triphasic waves. Epilepsy Behav. 2012, 25:170-3. 10.1016\/j.yebeh.2012.08.002","journal-title":"Epilepsy Behav"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.333486","article-title":"Chronic pregabalin abuse with subacute encephalopathy mimicking autoimmune encephalitis","volume":"69","author":"Harsha KJ","year":"2021","unstructured":"Harsha KJ, Joshy EV, Aravinda RV, Poornima R. Chronic pregabalin abuse with subacute encephalopathy mimicking autoimmune encephalitis. Neurol India. 2021, 69:1785-8. 10.4103\/0028-3886.333486","journal-title":"Neurol India"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P06.118","article-title":"Gabapentin neurotoxicity including posterior reversible leucoencephalopathy syndrome (PRES)","volume":"78","author":"Kleiman A","year":"2012","unstructured":"Kleiman A, Koppel B, Akfirat G, Chiechi M. Gabapentin neurotoxicity including posterior reversible leucoencephalopathy syndrome (PRES). Neurology. 2012, 78:","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004556","article-title":"Duloxetine-related posterior reversible encephalopathy syndrome: a case report","volume":"95","author":"Zappella N","year":"2016","unstructured":"Zappella N, Perier F, Pico F, et al.. Duloxetine-related posterior reversible encephalopathy syndrome: a case report. Medicine (Baltimore). 2016, 95:e4556. 10.1097\/MD.0000000000004556","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00513","article-title":"Effects of drugs of abuse on the blood-brain barrier: a brief overview","volume":"14","author":"Pimentel E","year":"2020","unstructured":"Pimentel E, Sivalingam K, Doke M, Samikkannu T. Effects of drugs of abuse on the blood-brain barrier: a brief overview. Front Neurosci. 2020, 14:513. 10.3389\/fnins.2020.00513","journal-title":"Front Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-020-0410-9","article-title":"Methadone-induced encephalopathy: a case series and literature review","volume":"20","author":"Haghighi-Morad M","year":"2020","unstructured":"Haghighi-Morad M, Naseri Z, Jamshidi N, Hassanian-Moghaddam H, Zamani N, Ahmad-Molaei L. Methadone-induced encephalopathy: a case series and literature review. BMC Med Imaging. 2020, 20:6. 10.1186\/s12880-020-0410-9","journal-title":"BMC Med Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9999481","article-title":"Posterior reversible encephalopathy syndrome (PRES) in a patient with opioid use disorder","volume":"2021","author":"Tumenta T","year":"2021","unstructured":"Tumenta T, Adeyemo S, Oladeji O, Jegede O, Laurent B, Olupona T. Posterior reversible encephalopathy syndrome (PRES) in a patient with opioid use disorder. Case Rep Psychiatry. 2021, 2021:9999481. 10.1155\/2021\/9999481","journal-title":"Case Rep Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e03005","article-title":"Opioid-induced toxic leukoencephalopathy: a case report and review of the literature","volume":"5","author":"Wheaton T","year":"2019","unstructured":"Wheaton T, Toll BJ, Breznak K, Da-Silva S, Melvin J, Misra A, Hwang SW. Opioid-induced toxic leukoencephalopathy: a case report and review of the literature. Heliyon. 2019, 5:e03005. 10.1016\/j.heliyon.2019.e03005","journal-title":"Heliyon"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99159-pregabalin-toxicity-induced-posterior-reversible-encephalopathy-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:44Z","timestamp":1707507884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99159-pregabalin-toxicity-induced-posterior-reversible-encephalopathy-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.25656","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,4]]}}}